文献速递外周动脉疾病

间歇性跛行患者的踝肱指数难以反映功能状态评估

Ankle-brachial index in patients with intermittent claudication is a poor indicator of patient-centered and clinician-based evaluations of functional status.
PubMed 文献 · J Vasc Surg · 2019-01-06

基于PORTRAIT研究1251例新发或加重间歇性跛行患者,比较踝肱指数(ABI)与Rutherford分级同外周动脉问卷(PAQ)评分的相关性。ABI与PAQ各维度相关性极弱,仅解释0.1%–2.1%的评分变异;Rutherford分级相关性更强但仍有限,解释3.2%–7.3%。结论提示患者自评健康状态不能由血流动力学或医师评估替代。

要点

  • ABI与PAQ评分相关性极弱,不能代表患者感知的症状与生活质量。
  • Rutherford分级与PAQ相关性略强,但仅解释3.2%–7.3%的变异。
  • 评估PAD对患者的影响应直接采用患者报告的功能状态工具。

核心结论

  • 在大型国际间歇性跛行队列中,以患者为中心的健康状态评估与医师或血流动力学评估仅弱相关。
  • 要准确衡量PAD对症状、功能能力和生活质量的影响,需直接评估患者,而非依赖生理或医师赋值评估。

研究设计与样本

  • PORTRAIT研究,纳入美国、荷兰、澳大利亚16个中心1251例新发或加重的间歇性跛行患者。
  • ABI分为轻度(>0.80)、中度(0.40-0.79)、重度(<0.40),计算ABI原始值与PAQ评分的Spearman秩相关系数。
  • 同时计算Rutherford分级与PAQ评分的Spearman秩相关系数。

主要发现

  • 平均ABI为0.67(标准差0.19);轻度PAD占24.3%,中度67.6%,重度8.1%。
  • Rutherford分级:1期22.7%,2期49.5%,3期27.8%。
  • ABI与PAQ总结评分r=0.09(95%CI 0.04-0.15),与体力受限评分r=0.14(95%CI 0.09-0.20)。
  • ABI与PAQ生活质量评分r=0.03(95%CI -0.02至0.09)、症状评分r=0.04(95%CI -0.01至0.10)无相关性。
  • ABI仅解释PAQ评分变异的0.1%–2.1%;Rutherford分级解释3.2%–7.3%。

关键数值与推荐

  • ABI分级:轻度>0.80,中度0.40-0.79,重度<0.40。
  • Rutherford分级与PAQ相关性:总结评分r=-0.27(95%CI -0.21至-0.32),生活质量r=-0.21(95%CI -0.16至-0.27),症状r=-0.18(95%CI -0.13至-0.23),体力受限r=-0.27(95%CI -0.22至-0.32)。

临床怎么用

  • 对间歇性跛行患者,不应仅凭ABI或Rutherford分级推断其症状负担与生活质量。
  • 临床决策与疗效评价应结合患者直接报告的健康状态工具(如PAQ)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The association between the severity of ankle-brachial index (ABI), a traditional measure of the severity of peripheral artery disease (PAD), and patients' perceptions of their health status is poorly characterized. In Patient-Centered Outcomes Related to Treatment Practices in Peripheral Artery Disease: Investigating Trajectories (PORTRAIT), a study of patients with intermittent claudication (IC), we studied the correlation of ABI values and Rutherford symptom classification with PAD-specific health status as measured by the Peripheral Artery Questionnaire (PAQ). METHODS: Among 1251 patients with new onset or exacerbation of IC enrolled at 16 sites in the United States, Netherlands, and Australia, ABI values were categorized as mild (>0.80), moderate (0.40-0.79), and severe (<0.40). Spearman rank correlation coefficients were calculated between raw ABI values and PAQ scores and between the Rutherford classification and PAQ scores. RESULTS: Mean ABI was 0.67 (standard deviation, 0.19); 24.3% had mild, 67.6% moderate, and 8.1% severe PAD. According to the Rutherford classification, 22.7% were stage 1 (mild claudication), 49.5% stage 2 (moderate claudication), and 27.8% stage 3 (severe claudication). Correlations (95% confidence interval) were found between ABI and the PAQ summary score (r = 0.09 [0.04-0.15]) and the PAQ physical limitations score (r = 0.14 [0.09-0.20]); no correlations were found between ABI and the PAQ quality of life score (r = 0.03 [-0.02 to 0.09]) and the PAQ symptoms score (r = 0.04 [-0.01 to 0.10]). With the correlations between ABI and PAQ scores, ABI explained only 0.1% to 2.1% of the variation in PAQ scores. Rutherford classification had stronger but still modest associations with PAQ scores (PAQ summary, r = -0.27 [-0.21 to -0.32]; PAQ quality of life, r = -0.21 [-0.16 to -0.27]; PAQ symptoms, r = -0.18 [-0.13 to -0.23]; PAQ physical limitations, r = -0.27 [-0.22 to -0.32]); Rutherford class explained 3.2% to 7.3% of the variation in PAQ scores. CONCLUSIONS: In a large, international cohort of patients with IC, patient-centered health status assessments are weakly associated with physicians' or hemodynamic assessments. To best measure the impact of PAD on patients' symptoms, functional capacity, and quality of life, direct assessment from patients is needed, rather than relying on physiologic or clinician-assigned assessments.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Johnston AL, Vemulapalli S, Gosch KL, et al. Ankle-brachial index in patients with intermittent claudication is a poor indicator of patient-centered and clinician-based evaluations of functional status. J Vasc Surg. 2019. PMID: 30626552. doi:10.1016/j.jvs.2018.07.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。